Cryo-Cell International Q3 net income, EPS rise
Cryo-Cell International Q3 net income, EPS rise
Overview
US cord blood bank's fiscal Q3 revenue was flat yr/yr
Net income and EPS rose yr/yr in fiscal Q3
Outlook
Company did not provide specific financial guidance for future periods
Result Drivers
FLAT REVENUE - Co did not provide specific reasons for its financial results
HIGHER NET INCOME - Co did not attribute net income increase to specific factors
Company press release: ID:nBw8rBtBDa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue |
| $7.82 mln |
|
Q3 EPS |
| $0.16 |
|
Q3 Net Income |
| $1.27 mln |
Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Reuters Recommended Reads
Oct 9 - Bagel franchisor BAB's Q3 net income rises 36% on lower overhead costs
Oct 7 - Consulting firm Resources Connection's Q1 net loss widens on lower project volume
Oct 7 - Cosmos Health Q3 revenue rises to record high on contract manufacturing
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)